Edward Sturchio
General Counsel chez IMMATICS N.V.
Fortune : 1 M $ au 31/03/2024
Profil
Edward Sturchio is currently the General Counsel at Immatics NV since 2020.
Prior to this, he worked as the Secretary, Senior Vice President & General Counsel at Abeona Therapeutics, Inc. from 2019 to 2020, and as the Secretary & Global General Counsel at Advanced Accelerator Applications SA from 2016 to 2018.
He completed his undergraduate degree at Villanova University and his graduate degree at Seton Hall University School of Law.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
IMMATICS N.V.
0,10% | 31/01/2024 | 106 875 ( 0,10% ) | 1 M $ | 31/03/2024 |
Postes actifs de Edward Sturchio
Sociétés | Poste | Début |
---|---|---|
IMMATICS N.V. | General Counsel | 01/06/2020 |
Anciens postes connus de Edward Sturchio
Sociétés | Poste | Fin |
---|---|---|
ABEONA THERAPEUTICS INC. | General Counsel | 01/02/2020 |
ADVANCED ACCELERATOR APPLICATION SA(ADR) | General Counsel | 01/08/2018 |
Formation de Edward Sturchio
Villanova University | Undergraduate Degree |
Seton Hall University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
IMMATICS N.V. | Health Technology |
Entreprise privées | 1 |
---|---|
Advanced Accelerator Applications SA
Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |